| Glenn Benard Mckenna, MD | |
|
800 N Fant St, Anderson, SC 29621-5708 | |
| (864) 512-1000 | |
| Not Available |
| Full Name | Glenn Benard Mckenna |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 800 N Fant St, Anderson, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609941251 | NPI | - | NPPES |
| Entity Name | Erx Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760823082 PECOS PAC ID: 9335037571 Enrollment ID: O20130930000326 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new data related to its overall delivery research efforts including the rational design of Mimetic Lipoprotein Particles, or MLPs, a novel technology for the systemic delivery of small interfering RNAs, or siRNAs, the molecules that mediate RNAi.
Adults with developmental disabilities such as autism and Down syndrome are having a harder time accessing health care even though they have more health issues than people without developmental disabilities, according to research done at the Institute for Clinical Evaluative Sciences and the Centre for Addiction and Mental Health.
Proton pump inhibitors, medications that suppress acid in the stomach, appear to be associated with fractures in postmenopausal women and bacterial infections in many patients, and higher doses do not appear any more beneficial for treating bleeding ulcers, according to a series of reports in the May 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A tool developed by researchers at Yale, Stanford, and Bioethics International can promote greater sharing of clinical trial data by pharmaceutical companies.
EndoChoice, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its BONASTENT® Fully Covered Esophageal Stent for the treatment of malignant esophageal obstructions, and its BONASTENT Uncovered Biliary Stent for the treatment of malignant biliary obstructions.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Glenn Benard Mckenna, MD 1116 Parker Pl Ne, Atlanta, GA 30324-5402 Ph: (404) 931-7978 | Glenn Benard Mckenna, MD 800 N Fant St, Anderson, SC 29621-5708 Ph: (864) 512-1000 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new data related to its overall delivery research efforts including the rational design of Mimetic Lipoprotein Particles, or MLPs, a novel technology for the systemic delivery of small interfering RNAs, or siRNAs, the molecules that mediate RNAi.
Adults with developmental disabilities such as autism and Down syndrome are having a harder time accessing health care even though they have more health issues than people without developmental disabilities, according to research done at the Institute for Clinical Evaluative Sciences and the Centre for Addiction and Mental Health.
Proton pump inhibitors, medications that suppress acid in the stomach, appear to be associated with fractures in postmenopausal women and bacterial infections in many patients, and higher doses do not appear any more beneficial for treating bleeding ulcers, according to a series of reports in the May 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A tool developed by researchers at Yale, Stanford, and Bioethics International can promote greater sharing of clinical trial data by pharmaceutical companies.
EndoChoice, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its BONASTENT® Fully Covered Esophageal Stent for the treatment of malignant esophageal obstructions, and its BONASTENT Uncovered Biliary Stent for the treatment of malignant biliary obstructions.
› Verified 6 days ago
James E. Reese, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-1335 | |
Michael Clarke, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-1000 | |
Dr. Kevin Matthew Summers, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 863-899-6081 | |
Dr. Zachary Hall Conn, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-607-3835 | |
David Scott Turner, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-1335 | |
Joseph Daniel Cox, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-1000 | |
Anthony W. Rekito, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 N Fant St, Anderson, SC 29621 Phone: 864-512-1335 |